Holen Sie sich die Stockscreener-App
8.50
11.99%
0.91
Handel nachbörslich:
8.58
0.08
+0.94%
Schlusskurs vom Vortag:
$7.59
Offen:
$7.57
24-Stunden-Volumen:
2.43M
Relative Volume:
1.08
Marktkapitalisierung:
$1.47B
Einnahmen:
$25.55M
Nettoeinkommen (Verlust:
$-341.97M
KGV:
-3.0357
EPS:
-2.8
Netto-Cashflow:
$-304.44M
1W Leistung:
+14.71%
1M Leistung:
-0.70%
6M Leistung:
+127.27%
1J Leistung:
+80.08%
1-Tages-Spanne:
$7.42
$8.635
1-Wochen-Bereich:
$7.36
$8.635
52-Wochen-Spanne:
$1.775
$9.04
Relay Therapeutics Inc Stock (RLAY) Company Profile
Firmenname
Relay Therapeutics Inc
Sektor
Branche
Telefon
617-370-8837
Adresse
60 HAMPSHIRE STREET, CAMBRIDGE
Vergleichen Sie RLAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
8.50 | 1.32B | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-09-04 | Fortgesetzt | Guggenheim | Buy |
| 2025-04-17 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-09-10 | Fortgesetzt | Goldman | Buy |
| 2024-09-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-09-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-05-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-04-20 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-04-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | Eingeleitet | Raymond James | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-09-30 | Eingeleitet | Barclays | Equal Weight |
| 2022-09-02 | Eingeleitet | Stifel | Buy |
| 2022-06-06 | Eingeleitet | Jefferies | Underperform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-07-21 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-11-05 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-10 | Eingeleitet | Cowen | Outperform |
| 2020-08-10 | Eingeleitet | Goldman | Buy |
| 2020-08-10 | Eingeleitet | Guggenheim | Buy |
| 2020-08-10 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Relay Therapeutics Inc Aktie (RLAY) Neueste Nachrichten
Oppenheimer Upgrades Relay Therapeutics (RLAY) - Nasdaq
Oppenheimer Upgrades Relay Therapeutics (RLAY) with Positive Out - GuruFocus
Oppenheimer upgrades Relay Therapeutics stock rating on gedatolisib concerns By Investing.com - Investing.com Canada
Relay Therapeutics (RLAY) Upgraded by Oppenheimer, Price Target Set at $14.00 | RLAY Stock News - GuruFocus
Relay Therapeutics stock rises after Oppenheimer upgrade By Investing.com - Investing.com Nigeria
Relay Therapeutics stock rises after Oppenheimer upgrade - Investing.com
Oppenheimer Upgrades Relay Therapeutics to Outperform From Market Perform, Price Target is $14 - marketscreener.com
Dip Buying: Can Relay Therapeutics Inc expand into new markets2025 Biggest Moves & Long-Term Growth Stock Strategies - baoquankhu1.vn
Published on: 2026-01-24 18:03:27 - baoquankhu1.vn
Analyst Calls: Will Relay Therapeutics Inc. stock hit new highs in YEARSell Signal & Technical Confirmation Alerts - baoquankhu1.vn
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Performance Recap: Can Relay Therapeutics Inc keep up with sector leadersWeekly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
Decliners Report: Can Relay Therapeutics Inc sustain its profitabilityJuly 2025 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Aug Intraday: Will Relay Therapeutics Inc stock hit new highs in YEAR2025 Technical Overview & Smart Swing Trading Alerts - baoquankhu1.vn
Relay Therapeutics, Inc. (RLAY) Stock Analysis: A Biotech Play with Potential 91% Upside Driven by Analyst Confidence - directorstalkinterviews.com
Guidance Update: How does FingerMotion Inc compare to its peersNew Guidance & Fast Moving Stock Watchlists - baoquankhu1.vn
Bearish Setup: What is the dividend yield of CPSSJuly 2025 Chart Watch & Fast Gaining Stock Reports - baoquankhu1.vn
Market Recap: Can Relay Therapeutics Inc keep up with sector leadersTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn
Why Relay Therapeutics Inc. stock could outperform in 2025Footwear buying guidance for daily running and walking routines focuses on joint friendly cushioning, making it a solid option for daily use. - ulpravda.ru
Aug Reactions: Can Relay Therapeutics Inc keep up with sector leadersEarnings Overview Summary & Weekly High Potential Alerts - baoquankhu1.vn
Aug Levels: Is Relay Therapeutics Inc stock showing strong momentumMarket Rally & Technical Confirmation Trade Alerts - baoquankhu1.vn
Have Relay Therapeutics Insiders Been Selling Stock? - simplywall.st
Is Relay Therapeutics Inc. stock a contrarian buyDollar Strength & Real-Time Stock Movement Alerts - Улправда
Will Relay Therapeutics Inc. stock deliver shareholder valueTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
Will Relay Therapeutics Inc. stock benefit from sector rotationQuarterly Risk Review & Low Risk Profit Maximizing Plans - ulpravda.ru
Will Relay Therapeutics Inc. stock split attract more investors2025 Technical Overview & Consistent Income Trade Recommendations - Улправда
How strong is Relay Therapeutics Inc. stock balance sheetWeekly Volume Report & Daily Oversold Bounce Ideas - ulpravda.ru
Why Relay Therapeutics Inc. stock could benefit from AI revolutionWall Street Watch & Weekly High Conviction Trade Ideas - Улправда
How Relay Therapeutics Inc. stock performs in rate cut cyclesRisk Management & Low Drawdown Trading Techniques - ulpravda.ru
CEO Change: Will Relay Therapeutics Inc. stock pay special dividendsEarnings Recap Summary & Daily Entry Point Trade Alerts - ulpravda.ru
Is Relay Therapeutics Inc. stock a buy before product launchesEnergy Sector Updates & Free Professional Investment Consultations - Улправда
Insider Selling: Relay Therapeutics (NASDAQ:RLAY) CEO Sells $337,573.76 in Stock - MarketBeat
User | guymondailyherald.comRelay Therapeutics, Inc.Common Stock (Nasdaq:RLAY) Stock Quote - FinancialContent
Relay Therapeutics Q3 2025 Earnings Preview - MSN
Relay Therapeutics announces analysis of data for zovegalisib - MSN
What makes Relay Therapeutics Inc. stock attractive to growth funds2026 world cup usa national team round of 32 goalkeepers low block defense knockout prediction guide - ulpravda.ru
Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN
Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking the 72.58% Potential Upside in Precision Medicine - DirectorsTalk Interviews
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week - MSN
Aug Action: What makes Relay Therapeutics Inc. stock attractive to growth fundsPortfolio Value Report & Weekly High Conviction Trade Ideas - moha.gov.vn
Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Take Profit: Can Relay Therapeutics Inc. stock hit record highs again2025 Valuation Update & Precise Trade Entry Recommendations - moha.gov.vn
Will Relay Therapeutics Inc. stock gain from strong economyFibonacci Retracement Levels & Analyze Your Portfolio Risk in Seconds - bollywoodhelpline.com
Relay Therapeutics (NASDAQ:RLAY) Shares Up 4.9%Here's What Happened - MarketBeat
Congress Asset Management Co. Has $2.13 Million Stock Holdings in Relay Therapeutics, Inc. $RLAY - MarketBeat
Relay Therapeutics signals slowdown to recharge after busy year - Traders Union
Will Relay Therapeutics Inc stock pay special dividendsMarket Sentiment Report & Verified Technical Signals - moha.gov.vn
Zovegalisib’s Consistent Efficacy Across Tough Subgroups Could Be A Game Changer For Relay (RLAY) - simplywall.st
What sentiment indicators say about Relay Therapeutics Inc. stockQuarterly Market Summary & High Win Rate Trade Alerts - Улправда
Can Relay Therapeutics Inc. stock hit analyst price targets2025 Sector Review & AI Enhanced Trading Alerts - Улправда
Is Relay Therapeutics Inc. stock attractive for passive investors2025 Biggest Moves & Risk Managed Investment Entry Signals - Улправда
Finanzdaten der Relay Therapeutics Inc-Aktie (RLAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):